Metabolic homeostasis is maintained in myocardial hibernation by adaptive changes in the transcriptome and proteome

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 6, 2011, Pages 982-990

  Mayr, Manuel ^a   May, Dalit ^b   Gordon, Oren ^b   Madhu, Basetti ^c   Gilon, Dan ^b   Yin, Xiaoke ^a   Xing, Qiuru ^a   Drozdov, Ignat ^d   Ainali, Chrysanthi ^d   Tsoka, Sophia ^d   Xu, Qingbo ^a   Griffiths, John ^c   Horrevoets, Anton ^e   Keshet, Eli ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hibernation; Hypoxia; Metabolomics; Myocardium; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; PROTEOME; TRANSCRIPTOME; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOINFORMATICS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GLUCOSE METABOLISM; GLYCOLYSIS; HEART MUSCLE METABOLISM; HOMEOSTASIS; LIPID METABOLISM; METABOLOMICS; MOUSE; MYOCARDIAL HIBERNATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMEOSTASIS; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, TRANSGENIC; MYOCARDIAL STUNNING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MUS MUSCULUS;

EID: 79955650300     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.02.010     Document Type: Article

References (41)

1. Rahimtoola S.H. The hibernating myocardium. Am. Heart J. 1989, 117(1):211-221.
2. Depre C., Vatner S.F. Mechanisms of cell survival in myocardial hibernation. Trends Cardiovasc. Med. 2005, 15(3):101-110.
3. Opie L.H. Heart physiology: from cell to circulation 2004, Lippincott Williams & Wilkins, Philadelphia. 4th ed.
4. Heusch G., Schulz R., Rahimtoola S.H. Myocardial hibernation: a delicate balance. Am. J. Physiol. Heart Circ. Physiol. 2005, 288(3):H984-H999.
5. Heusch G., Schulz R. The biology of myocardial hibernation. Trends Cardiovasc. Med. 2000, 10(3):108-114.
6. Page B., Young R., Iyer V., Suzuki G., Lis M., Korotchkina L., et al. Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium. Circ. Res. 2008, 102(1):103-112.
7. May D., Gilon D., Djonov V., Itin A., Lazarus A., Gordon O., et al. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc. Natl Acad. Sci. USA 2008, 105(1):282-287.
8. Mayr M., Metzler B., Chung Y.L., McGregor E., Mayr U., Troy H., et al. Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(2):H946-H956.
9. Mayr M., Chung Y.L., Mayr U., McGregor E., Troy H., Baier G., et al. Loss of PKC-delta alters cardiac metabolism. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(2):H937-H945.
10. Mayr M., Liem D., Zhang J., Li X., Avliyakulov N.K., Yang J.I., et al. Proteomic and metabolomic analysis of cardioprotection: interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J. Mol. Cell. Cardiol. 2009, 46(2):268-277.
11. Mayr M., Madhu B., Xu Q. Proteomics and metabolomics combined in cardiovascular research. Trends Cardiovasc. Med. 2007, 17(2):43-48.
12. Puntmann V.O., Mayr M. Phenotyping transgenic animals-an integrated readout of pathophysiology by combining proteomics and metabolomics with cardiovascular imaging. J. Mol. Cell. Cardiol. 2010, 48(4):571-573.
13. Mayr M., Siow R., Chung Y.L., Mayr U., Griffiths J.R., Xu Q. Proteomic and metabolomic analysis of vascular smooth muscle cells: role of PKCdelta. Circ. Res. 2004, 94(10):e87-e96.
14. Taegtmeyer H., Sen S., Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. NY Acad. Sci. 2010, 1188:191-198.
15. van der Velden J., Merkus D., Klarenbeek B.R., James A.T., Boontje N.M., Dekkers D.H., et al. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ. Res. 2004, 95(11):e85-e95.
16. Rabilloud T., Heller M., Gasnier F., Luche S., Rey C., Aebersold R., et al. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002, 277(22):19396-19401.
17. Mayr M., Chung Y.L., Mayr U., Yin X., Ly L., Troy H., et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25(10):2135-2142.
18. Dhar-Chowdhury P., Harrell M.D., Han S.Y., Jankowska D., Parachuru L., Morrissey A., et al. The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the K(ATP) channel macromolecular complex and regulate its function. J. Biol. Chem. 2005, 280(46):38464-38470.
19. Jovanovic S., Du Q., Crawford R.M., Budas G.R., Stagljar I., Jovanovic A. Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal K(ATP) channel. EMBO Rep. 2005, 6(9):848-852.
20. Carrasco A.J., Dzeja P.P., Alekseev A.E., Pucar D., Zingman L.V., Abraham M.R., et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc. Natl Acad. Sci. USA 2001, 98(13):7623-7628.
21. Rumsey W.L., Abbott B., Bertelsen D., Mallamaci M., Hagan K., Nelson D., et al. Adaptation to hypoxia alters energy metabolism in rat heart. Am. J. Physiol. 1999, 276(1 Pt 2):H71-H80.
22. Fell D. Understanding the control of metabolism 1996, Portland Press, London. 1st ed.
23. Chance B., Williams G.R. The respiratory chain and oxidative phosphorylation. Adv. Enzymol. Relat. Subj. Biochem. 1956, 17:65-134.
24. Chance B., Williams G.R. Respiratory enzymes in oxidative phosphorylation. VI. The effects of adenosine diphosphate on azide-treated mitochondria. J Biol Chem 1956, 221(1):477-489.
25. Balaban R.S. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 2002, 34(10):1259-1271.
26. Cortassa S., O'Rourke B., Winslow R.L., Aon M.A. Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function. Biophys. J. 2009, 96(6):2466-2478.
27. Depre C., Kim S.J., John A.S., Huang Y., Rimoldi O.E., Pepper J.R., et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ. Res. 2004, 95(4):433-440.
28. 2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(6):H2712-H2718.
29. 2+-sensitivity of myofilaments in human heart failure. Cardiovasc. Res. 2003, 57(1):5-7.
30. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc. Res. 2003, 57(1):37-47.
31. Kane G.C., Liu X.K., Yamada S., Olson T.M., Terzic A. Cardiac KATP channels in health and disease. J. Mol. Cell. Cardiol. 2005, 38(6):937-943.
32. Hochachka P.W., Buck L.T., Doll C.J., Land S.C. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc. Natl Acad. Sci. USA 1996, 93(18):9493-9498.
33. Kroll K., Decking U.K., Dreikorn K., Schrader J. Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ. Res. 1993, 73(5):846-856.
34. Kroll K., Kinzie D.J., Gustafson L.A. Open-system kinetics of myocardial phosphoenergetics during coronary underperfusion. Am. J. Physiol. 1997, 272(6 Pt 2):H2563-H2576.
35. Peart J.N., Gross G.J. Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res. Cardiol. 2005, 100(4):328-336.
36. Wieland B., Tomasselli A.G., Noda L.H., Frank R., Schulz G.E. The amino acid sequence of GTP:AMP phosphotransferase from beef-heart mitochondria. Extensive homology with cytosolic adenylate kinase. Eur. J. Biochem. 1984, 143(2):331-339.
37. Liu R., Strom A.L., Zhai J., Gal J., Bao S., Gong W., et al. Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase. Int. J. Biochem. Cell Biol. 2009, 41(6):1371-1380.
38. Wallis J., Lygate C.A., Fischer A., ten Hove M., Schneider J.E., Sebag-Montefiore L., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 2005, 112(20):3131-3139.
39. Phillips D., Ten Hove M., Schneider J.E., Wu C.O., Sebag-Montefiore L., Aponte A.M., et al. Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J. Mol. Cell. Cardiol. 2010, 48(4):582-590.
40. Cannon W.A. On the variation of the oxygen content of cultural solutions. Science 1932, 75(1934):108-109.
41. Schoenheimer R., Rittenberg D. The application of isotopes to the study of intermediary metabolism. Science 1938, 87(2254):221-226.